By Priyanjana Pramanik, MSc. Researchers reveal why lung cancer in people who never smoked is increasing and explore how ...

The FDA has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneous, chemo-free ...

Researchers have identified a biological mechanism that helps explain why some lung and ovarian cancers become resistant to ...

Even non-smokers may face up to seven times higher risk of developing lung cancer if they have a history of chronic lung disease or a family history, according to a new study. A joint research team ...

FDA RMAT boosts inhaled gene therapy KB707, delivering IL‑2/IL‑12 to lung tumors; early trial shows responses with manageable ...

New Members Bring Expertise in Immunology, Genomics, Clinical Oncology, and Patient Advocacy to Guide LCFA's Research Investments and Accelerate Breakthroughs ...

The study, published today in Cancer Cell, generated spatial transcriptomic maps in precancerous and more advanced stages of lung cancer to provide a deeper understanding of early lung cancer ...

A new randomized clinical trial showed that receiving immunochemotherapy infusions earlier in the day may help patients with ...

Spatial maps of lung precancer and cancer cells at different points in development advance understanding of the earliest stages of lung cancer Findings highlight inflammation as a driver of lung tumor ...

Most people associate lung cancer primarily with smoking, but growing evidence suggests diet plays a more significant role than previously thought. While numerous foods help protect against cancer, ...

Late detection, high smoking rates and limited screening have made lung cancer the deadliest cancer in Vietnam, prompting urgent calls to shift toward prevention and early diagnosis.